Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
2023 · The Lancet Diabetes & Endocrinology · 75 citations
https://doi.org/10.1016/s2213-8587(23)00316-9
N
Na Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
1.1K
Citations
18
h-index
32
i10-index
Na Li is an academic researcher from Tianjin University. The author has contributed to research in topics: Corneal surgery and disorders & Glaucoma and retinal disorders & Corneal Surgery and Treatments. The author has an h-index of 18, co-authored 97 publications.
ORCID: 0000-0002-8961-5620Papers by this author
worksEffect of Akkermansia muciniphila on pancreatic islet β-cell function in rats with prediabetes mellitus induced by a high-fat diet
2024 · Bioresources and Bioprocessing · 10 citations
https://doi.org/10.1186/s40643-024-00766-4
Metformin and berberine synergistically improve NAFLD via the AMPK–SREBP1–FASN signaling pathway
2025 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-025-15495-7
Application of Preoperative Adductor Canal Block Coupled with General Anaesthesia in Elderly Patients Undergoing Total Knee Arthroplasty
2022 · Disease Markers · 2 citations
https://doi.org/10.1155/2022/3071665
Changes in aberrations and biomechanics after femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) in eyes with high astigmatism: a retrospective case control study
2023 · BMC Ophthalmology · 2 citations
https://doi.org/10.1186/s12886-023-02809-4
Low expression of RACK1 is associated with metastasis and worse prognosis in cholangiocarcinoma
2024 · Heliyon · 2 citations
https://doi.org/10.1016/j.heliyon.2024.e27366
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat